Financial Gravity Asset Management’s ChemoCentryx, Inc. CCXI Stock Holding History

Financial Gravity Asset Management’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	$0	Buy	+2	New	+$115	﹤0.01%	697

Other funds holding CCXI

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

PAMU

Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Financial Gravity Asset Management's CCXI Position: Q4 2020 in Review

Financial Gravity Asset Management opened a new position in ChemoCentryx, Inc. (CCXI) in Q4 2020: 2 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #697 among its holdings.

196 funds tracked by Wall St. Rank hold CCXI as of Q4 2020.

Financial Gravity Asset Management held 2 shares of ChemoCentryx, Inc. worth $0 as of Q4 2020.
ChemoCentryx, Inc. was a new Financial Gravity Asset Management position in Q4 2020.
ChemoCentryx, Inc. made up ﹤0.01% of Financial Gravity Asset Management's portfolio in Q4 2020, its #697 holding.
196 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2020.

Based on Financial Gravity Asset Management's 13F filing for Q4 2020, filed 16 Feb 2021.